These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 29064619)

  • 21. Role of ADAMTS13 in the management of thrombotic microangiopathies including thrombotic thrombocytopenic purpura (TTP).
    Shah N; Rutherford C; Matevosyan K; Shen YM; Sarode R
    Br J Haematol; 2013 Nov; 163(4):514-9. PubMed ID: 24111495
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potential modifications of the PLASMIC scoring system for predicting thrombotic thrombocytopenic purpura: Sometimes, less is more.
    Orhan B; Özkocaman V; Akdemir Ç; Ersal T; Pınar İE; Yalçın C; Candar Ö; Çubukçu S; Koca TG; Ambarcıoğlu P; Ali R; Özkalemkaş F
    Int J Lab Hematol; 2023 Oct; 45(5):751-757. PubMed ID: 37309683
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The course of ADAMTS-13 activity and inhibitor titre in the treatment of thrombotic thrombocytopenic purpura with plasma exchange and vincristine.
    Böhm M; Betz C; Miesbach W; Krause M; von Auer C; Geiger H; Scharrer I
    Br J Haematol; 2005 Jun; 129(5):644-52. PubMed ID: 15916687
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics of plasma infusion in congenital thrombotic thrombocytopenic purpura.
    Taylor A; Vendramin C; Oosterholt S; Della Pasqua O; Scully M
    J Thromb Haemost; 2019 Jan; 17(1):88-98. PubMed ID: 30475428
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Platelet rescue by macrophage depletion in obese ADAMTS-13-deficient mice at risk of thrombotic thrombocytopenic purpura.
    Geys L; Roose E; Scroyen I; Rottensteiner H; Tersteeg C; Hoylaerts MF; Vanhoorelbeke K; Lijnen HR
    J Thromb Haemost; 2018 Jan; 16(1):150-163. PubMed ID: 29121438
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanism underlying severe deficiency of plasma ADAMTS-13 activity in immune thrombotic thrombocytopenic purpura.
    Zheng XL
    J Thromb Haemost; 2024 May; 22(5):1358-1365. PubMed ID: 38360215
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Utility of Different Scoring Systems for the Diagnosis of Thrombotic Microangiopathies.
    Yilmaz S; Cenelİ O; Tekinalp A
    J Coll Physicians Surg Pak; 2023 May; 33(5):539-543. PubMed ID: 37190689
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ADAMTS13 test and/or PLASMIC clinical score in management of acquired thrombotic thrombocytopenic purpura: a cost-effective analysis.
    Kim CH; Simmons SC; Williams LA; Staley EM; Zheng XL; Pham HP
    Transfusion; 2017 Nov; 57(11):2609-2618. PubMed ID: 28646526
    [TBL] [Abstract][Full Text] [Related]  

  • 29.
    Kim Y; Ahn A; Lee JM; Kim M; Lee HK; Kim H
    Ann Clin Lab Sci; 2024 Mar; 54(2):265-269. PubMed ID: 38802156
    [No Abstract]   [Full Text] [Related]  

  • 30. Child-onset and adolescent-onset acquired thrombotic thrombocytopenic purpura with severe ADAMTS13 deficiency: a cohort study of the French national registry for thrombotic microangiopathy.
    Joly BS; Stepanian A; Leblanc T; Hajage D; Chambost H; Harambat J; Fouyssac F; Guigonis V; Leverger G; Ulinski T; Kwon T; Loirat C; Coppo P; Veyradier A;
    Lancet Haematol; 2016 Nov; 3(11):e537-e546. PubMed ID: 27720178
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiac troponin-I on diagnosis predicts early death and refractoriness in acquired thrombotic thrombocytopenic purpura. Experience of the French Thrombotic Microangiopathies Reference Center.
    Benhamou Y; Boelle PY; Baudin B; Ederhy S; Gras J; Galicier L; Azoulay E; Provôt F; Maury E; Pène F; Mira JP; Wynckel A; Presne C; Poullin P; Halimi JM; Delmas Y; Kanouni T; Seguin A; Mousson C; Servais A; Bordessoule D; Perez P; Hamidou M; Cohen A; Veyradier A; Coppo P;
    J Thromb Haemost; 2015 Feb; 13(2):293-302. PubMed ID: 25403270
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictive Value of Schistocytes in Recurrence of Acquired Thrombotic Thrombocytopenic Purpura With Severe ADAMTS13 Deficiency at Discontinuation of Daily Therapeutic Plasma Exchange.
    Peedin AR; Park YA; Mazepa MA; Rollins-Raval MA; Brecher ME; Raval JS
    Ther Apher Dial; 2018 Dec; 22(6):662-665. PubMed ID: 30178615
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ADAMTS-13 may not predict disease or outcome in patients with Thrombotic Thrombocytopenic Purpura.
    Rock G; Clark WF; Anderson D; Benny B; Sutton D; Leblond P; Sternbach M; Sontrop J;
    Thromb Res; 2013 Apr; 131(4):308-12. PubMed ID: 23411128
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Consensus on the standardization of terminology in thrombotic thrombocytopenic purpura and related thrombotic microangiopathies.
    Scully M; Cataland S; Coppo P; de la Rubia J; Friedman KD; Kremer Hovinga J; Lämmle B; Matsumoto M; Pavenski K; Sadler E; Sarode R; Wu H;
    J Thromb Haemost; 2017 Feb; 15(2):312-322. PubMed ID: 27868334
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preclinical assessment of a new recombinant ADAMTS-13 drug product (BAX930) for the treatment of thrombotic thrombocytopenic purpura.
    Kopić A; Benamara K; Piskernik C; Plaimauer B; Horling F; Höbarth G; Ruthsatz T; Dietrich B; Muchitsch EM; Scheiflinger F; Turecek M; Höllriegl W
    J Thromb Haemost; 2016 Jul; 14(7):1410-9. PubMed ID: 27371116
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ADAMTS13 Testing Methodologies and Thrombotic Thrombocytopenic Purpura (TTP): Conflicting Results Can Pose a Clinical Dilemma.
    Pandey S; Cottler-Fox M
    Ann Clin Lab Sci; 2018 May; 48(3):373-376. PubMed ID: 29970443
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk of diagnostic delay in congenital thrombotic thrombocytopenic purpura.
    Ferrari B; Cairo A; Pagliari MT; Mancini I; Arcudi S; Peyvandi F
    J Thromb Haemost; 2019 Apr; 17(4):666-669. PubMed ID: 30762934
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ADAMTS-13 activity and autoantibodies classes and subclasses as prognostic predictors in acquired thrombotic thrombocytopenic purpura.
    Bettoni G; Palla R; Valsecchi C; Consonni D; Lotta LA; Trisolini SM; Mancini I; Musallam KM; Rosendaal FR; Peyvandi F
    J Thromb Haemost; 2012 Aug; 10(8):1556-65. PubMed ID: 22672482
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A validation and modification of PLASMIC score by adjusting the criteria of mean corpuscular volume and international normalized ratio.
    Lee JA; Lin MH; Kang CM; Chuang MK; Fung CKB; Lo SC
    J Clin Apher; 2023 Oct; 38(5):582-589. PubMed ID: 37325919
    [TBL] [Abstract][Full Text] [Related]  

  • 40. COVID 19 infection associated with thrombotic thrombocytopenic purpura.
    Dhingra G; Maji M; Mandal S; Vaniyath S; Negi G; Nath UK
    J Thromb Thrombolysis; 2021 Aug; 52(2):504-507. PubMed ID: 33904053
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.